J Neurol Neurosur Ps:工作日入院的卒中患者有更好的预后

2015-09-06 phylis 译 MedSci原创

背景:医疗环境中存在着“周末”效应,但是对卒中患者的影响尚不清楚。目的:调查卒中入院时间对患者处理过程以及卒中预后的影响。方法:应用苏格兰数据库(2005-2013)中的数据,入院时间分为工作日,周日晚上以及周末/公共节假日。主要的处理措施为入院当天的吞咽功能筛查,脑扫描(0或1天),应用阿司匹林(0或1天),入住卒中病房(0或1天),溶栓治疗(0或1天)。校正病例混杂因素后,应用多变量logis

背景:医疗环境中存在着“周末”效应,但是对卒中患者的影响尚不清楚。

目的:调查卒中入院时间对患者处理过程以及预后的影响。

方法:应用苏格兰数据库(2005-2013)中的数据,入院时间分为工作日、周日晚上、以及周末/公共节假日。主要的处理措施为入院当天的吞咽功能筛查、脑扫描(0或1天)、应用阿司匹林(0或1天)、入住卒中病房(0或1天)、溶栓治疗(0或1天)。校正病例混杂因素后,应用多变量logistic回归预测患者死亡率以及患者出院的OR值。

结果:
共52276名卒中患者。与工作日相比,周日晚上入院的卒中患者,入住卒中病房的校正OR值(95%CI)为0.81 (0.77 to 0.85),周末/节假日入院的卒中患者的校正OR值为0.64 (0.61 to 0.67);早期脑扫描校正OR值分别为1.30 (0.87 to 1.94) 和1.43 (0.95 to 2.18);当天吞咽功能筛查的校正OR值分别为0.86 (0.81 to 0.91) 和0.85 (0.81 to 0.90);溶栓治疗的OR值分别为:0.85 (0.75 to 0.97) 和0.85 (0.75 to 0.97)。与工作日入院患者相比,周末入院患者七天死亡率,30天死亡率以及30天出院率校正OR值分别 1.17 (1.05 to 1.30); 1.08 (1.00 to 1.17); 和 0.90 (0.85 to 0.95)。

结论:在工作时间之外,周末或者公共节假日入院的卒中患者,可不按照指南及时处理。校正已知的独立于预后和早期死亡率的预测因子,发现在正常工作日入院的卒中患者短期预后较好。

原文出处:

Turner M, Barber M, Dodds H,et al. Stroke patients admitted within normal working hours are more likely to achieve process standards and to have better outcomes. J Neurol Neurosurg Psychiatry. 2015 Aug 18. 


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1973962, encodeId=558c19e3962cb, content=<a href='/topic/show?id=6bcf4e887c7' target=_blank style='color:#2F92EE;'>#工作日#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47887, encryptionId=6bcf4e887c7, topicName=工作日)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Thu Apr 21 23:40:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720053, encodeId=20dc1e20053ab, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Tue Sep 22 01:40:00 CST 2015, time=2015-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999558, encodeId=8f861999558b9, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Dec 25 05:40:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364056, encodeId=12b1136405613, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Tue Sep 08 10:40:00 CST 2015, time=2015-09-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1973962, encodeId=558c19e3962cb, content=<a href='/topic/show?id=6bcf4e887c7' target=_blank style='color:#2F92EE;'>#工作日#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47887, encryptionId=6bcf4e887c7, topicName=工作日)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Thu Apr 21 23:40:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720053, encodeId=20dc1e20053ab, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Tue Sep 22 01:40:00 CST 2015, time=2015-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999558, encodeId=8f861999558b9, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Dec 25 05:40:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364056, encodeId=12b1136405613, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Tue Sep 08 10:40:00 CST 2015, time=2015-09-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1973962, encodeId=558c19e3962cb, content=<a href='/topic/show?id=6bcf4e887c7' target=_blank style='color:#2F92EE;'>#工作日#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47887, encryptionId=6bcf4e887c7, topicName=工作日)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Thu Apr 21 23:40:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720053, encodeId=20dc1e20053ab, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Tue Sep 22 01:40:00 CST 2015, time=2015-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999558, encodeId=8f861999558b9, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Dec 25 05:40:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364056, encodeId=12b1136405613, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Tue Sep 08 10:40:00 CST 2015, time=2015-09-08, status=1, ipAttribution=)]
    2015-12-25 yinhl1978
  4. [GetPortalCommentsPageByObjectIdResponse(id=1973962, encodeId=558c19e3962cb, content=<a href='/topic/show?id=6bcf4e887c7' target=_blank style='color:#2F92EE;'>#工作日#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47887, encryptionId=6bcf4e887c7, topicName=工作日)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Thu Apr 21 23:40:00 CST 2016, time=2016-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720053, encodeId=20dc1e20053ab, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Tue Sep 22 01:40:00 CST 2015, time=2015-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999558, encodeId=8f861999558b9, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Dec 25 05:40:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364056, encodeId=12b1136405613, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Tue Sep 08 10:40:00 CST 2015, time=2015-09-08, status=1, ipAttribution=)]
    2015-09-08 lsndxfj

相关资讯

ESC 2015:多危险因素引发卒中效果匹敌房颤

ESC房颤专场,中国人民解放军总医院郭豫涛教授报告的真实世界研究显示,在老年患者中,房颤对缺血性卒中的影响被多种危险因素的影响所抵消。预防老年卒中需关注多种危险因素的共同影响,而不是只关注某种特定危险因素、例如房颤。 研究共纳入425600例无卒中病史患者,其中63.8%为男性,平均年龄60岁,880例患者有房颤,424720例无房颤。总体上,缺血性卒中发病率在非房颤人群为0.35/100人-年

行医请勿过劳:柳叶刀研究表明过劳易致卒中

又一位麻醉医生倒在了值夜班的工作岗位上!8月22日晚上九点多,厦门长庚医院麻醉科医生孙彪主任在值夜班做麻醉的时候,突发颅内出血倒下去了,脑室出血,现在仍在重症监护室里,病危病重…这个消息让人心情沉重!这不禁让人想起了之前过劳致死的许多案例,为什么过劳所造成的疾病大多在心、脑血管发病,这二者间又什么联系呢?近日,目前调查心血管疾病与工作时间关联的诸多研究中样本量最大的一个在Lancet上发表了新

Stroke:机械通气的卒中患者再入院率增高?

气管切开术是严重缺血性卒中,脑出血,蛛网膜下腔出血患者常用的处理方式。但是对行机械通气的卒中患者的再入院率的了解较少。我们按照国际疾病分类法,第九版临床修订准则,收集3个州的非联邦急诊护理医院所有的出院患者的数据。我们比较行机械通气的卒中患者的再入院率,这些卒中患者分为行气管切开术和未行气管切开术两类。在39881名在卒中住院期间行机械通气,并且存活到出院的患者,10690名(26.8%, 95%

J Stroke Cerebrovasc Dis:他汀类药物能够降低LDL-C急性卒中患者的死亡率

为了调查住院患者他汀类药物治疗对低密度脂蛋白胆固醇(LDL-C<1.81 mmol/L)水平的急性卒中患者死亡率的影响。从中国国家登记表中招募急性卒中患者,患者LDL-C低于1.81 mmol/L。住院期间根据患者是否应用他汀类治疗,将患者分为他汀组和非他汀组。应用多变量二元logistic回归模型分析患者进行他汀类药物治疗和患者1年死亡率之间的关系。招募了1018名患者,3个月累积死亡率为

Lancet:长时间工作可增加卒中的发生风险

Lancet:长时间工作可增加卒中的发生风险据发表于Lancet上的一项新的研究显示,每周工作55小时及以上的人发生卒中的风险可增加33%,此外发生冠心病的风险也较高。该研究是调查心血管疾病与工作时间关联的诸多研究中样本量最大的一个。去年,今日医学新闻报道,与每周仅工作40小时及以下的人相比,每周工作61-70小时的工作狂患冠心病的风险可升高42%。据去年的一项调查显示,大多数美国人平均每周的工作

Stroke:卒中患者配偶的长期健康生活质量下降?

研究者普遍研究卒中患者对家庭短期的影响。这篇研究主要想评估卒中患者配偶长期的健康相关生活质量。在萨尔格学院缺血性卒中研究中收集卒中患者,对照组和配偶7年随访的相关数据。应用SF-36评估配偶健康相关生活质量,用NIHSS,简易精神状态量表,抑郁量表,焦虑量表,BI以及mRS评估卒中患者的状况。招募248对卒中患者,初发卒中小于70岁,245对为对照组。卒中患者配偶和对照组配偶的年龄的中位数分别为6